Acacia’s Anti-Nausea Treatment Stumbles Again

Drug Industry Daily
A A
Acacia Pharma’s anti-nausea drug Barhemsys has stalled again, with the FDA issuing a second complete response letter in less than a year over problems at the plant that makes the drug’s main ingredient.

To View This Article:

Login

Subscribe To Drug Industry Daily